Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial.

导出 OA

翻译打印收藏纠错

作者： Emilia,Montagna ^[1] ; Vincenzo,Bagnardi ^[2] ; Giuseppe,Cancello ^[1] ; Claudia,Sangalli ^[1] ; Eleonora,Pagan ^[2] ; Monica,Iorfida ^[1] ; Manuelita,Mazza ^[1] ; Giovanni,Mazzarol ^[3] ; Silvia,Dellapasqua ^[1] ; Elisabetta,Munzone ^[1] ; Aaron,Goldhirsch ^[4] ; Marco,Colleoni ^[1]

作者单位： Division of Medical Senology, European Institute of Oncology, Milan, Italy. ^[1] Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy. ^[2] Division of Pathology, European Institute of Oncology, Milan, Italy. ^[3] European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. ^[4]

关键词 Breast cancer Metastatic disease Metronomic Treatment strategies

DOI 10.1159/000487630

PMID 30069178

发布时间 2022-03-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交